about
The PKC targeting protein RACK1 interacts with the Epstein-Barr virus activator protein BZLF1The C-terminus of Raf-1 acts as a 14-3-3-dependent activation switchMechanism of suppression of the Raf/MEK/extracellular signal-regulated kinase pathway by the raf kinase inhibitor proteinbeta2-chimaerin is a novel target for diacylglycerol: binding properties and changes in subcellular localization mediated by ligand binding to its C1 domainProteomics for prediction of disease progression and response to therapy in diabetic kidney diseaseProteomic candidate biomarkers of drug-induced nephrotoxicity in the ratSuppression of Raf-1 kinase activity and MAP kinase signalling by RKIPAssignment of the protein kinase C delta polypeptide gene (PRKCD) to human chromosome 3 and mouse chromosome 14Human Proteinpedia enables sharing of human protein dataProteasix: a tool for automated and large-scale prediction of proteases involved in naturally occurring peptide generationStructural mechanism for lipid activation of the Rac-specific GAP, beta2-chimaerinUrinary collagen fragments are significantly altered in diabetes: a link to pathophysiologyPeptide fingerprinting of Alzheimer's disease in cerebrospinal fluid: identification and prospective evaluation of new synaptic biomarkersA distinct urinary biomarker pattern characteristic of female Fabry patients that mirrors response to enzyme replacement therapyUrinary proteomics to support diagnosis of strokeEvaluation of the Zucker diabetic fatty (ZDF) rat as a model for human disease based on urinary peptidomic profilesUrinary proteomic biomarkers for diagnosis and risk stratification of autosomal dominant polycystic kidney disease: a multicentric studyProteomics as a Quality Control Tool of Pharmaceutical Probiotic Bacterial Lysate ProductsLong term metabolic syndrome induced by a high fat high fructose diet leads to minimal renal injury in C57BL/6 miceComparative Analysis of Label-Free and 8-Plex iTRAQ Approach for Quantitative Tissue Proteomic AnalysisPKC zeta enhances insulin-like growth factor 1-dependent mitogenic activity in the rat clonal beta cell line RIN 1046-38Protein kinase C delta activation and translocation to the nucleus are required for fatty acid-induced apoptosis of insulin-secreting cellsMulticentric validation of proteomic biomarkers in urine specific for diabetic nephropathyNaturally occurring human urinary peptides for use in diagnosis of chronic kidney disease.CE-MS analysis of the human urinary proteome for biomarker discovery and disease diagnostics.Pilot study of capillary electrophoresis coupled to mass spectrometry as a tool to define potential prostate cancer biomarkers in urine.Discovery and validation of urinary biomarkers for prostate cancerCapillary electrophoresis-mass spectrometry as a powerful tool in biomarker discovery and clinical diagnosis: an update of recent developmentsDiscovery and validation of new protein biomarkers for urothelial cancer: a prospective analysis.Mass spectrometry based proteomics in urine biomarker discovery.Differential polypeptide display: the search for the elusive target.Integrating proteomics profiling data sets: a network perspective.Proteomics: a novel tool to unravel the patho-physiology of uraemia.Classical MALDI-MS versus CE-based ESI-MS proteomic profiling in urine for clinical applications.Discovery of biomarkers in human urine and cerebrospinal fluid by capillary electrophoresis coupled to mass spectrometry: towards new diagnostic and therapeutic approaches.Phosphorylation of GRK2 by protein kinase C abolishes its inhibition by calmodulin.Effects of oral vitamin C supplementation in hemodialysis patients: a proteomic assessment.Value of proteomics applied to the follow-up in stem cell transplantation.Biomarker discovery by CE-MS enables sequence analysis via MS/MS with platform-independent separation.Adapting mass spectrometry-based platforms for clinical proteomics applications: The capillary electrophoresis coupled mass spectrometry paradigm.
P50
Q22254235-4E0366BC-F3F8-492B-9AAC-8BC2365541E7Q24313905-DAD8D762-B655-49D1-99DF-B95263F455C5Q24554247-72D9CA78-E625-4E6B-9B10-296729D8F31CQ24675064-93220393-8215-4827-AE14-C3F578238B76Q26747131-492477FA-D1E5-48A4-A6D4-D771DE6F1C10Q27305109-ABD66D10-59A2-470A-896B-469F16317335Q28144497-709A132E-5DE7-4A1C-849E-06AF39D6D5BFQ28253791-9E9D3A0D-8AC9-4BAE-AB12-E59DAD00C7C4Q28267923-26E0336B-2DB5-4A1E-B707-E92111B7ED76Q28284158-DE953E49-FF4A-450C-9B76-68865AEDFC27Q28289919-22FAA2BE-27E5-458F-ABBB-D493A9A22427Q28475613-1E6CD838-8277-467D-BCF4-557415260E8AQ28477629-EB17295A-A173-4D73-A7F5-76BD4D6CE4CEQ28478586-CDB5D8A7-4477-4503-8865-152B3F09AAB0Q28483776-8CD9B1CF-876A-43F0-9168-67B514AFD8F2Q28484239-C31AADDD-FF1C-469C-82D5-733010673719Q28484968-7ADB4865-5BBA-4234-877C-B7D6727BA66EQ28533986-9AE056D2-10D2-48A5-BC88-A620FBABD9A5Q28534010-15491E1C-F18A-4C50-8C63-08F373536C7CQ28547700-76956468-90E6-42D0-9FAB-3F707C2BF556Q28565690-29A3BD22-9234-4432-9DA2-F9AE50687B15Q28583477-59AB6290-92C3-437D-A5B2-C56C02A47D43Q28748796-2666A118-A3A4-463B-AFCD-6E68EDCF220EQ30430034-1F728E27-47F0-4C5C-9EB1-9721BE2F02A2Q30437141-85A1BF40-D211-48AF-A2F1-E7020F6FC94BQ30437217-BF1A7DD1-F896-4A20-8E2B-5EE0C0B3F4F2Q30438582-0F1F96B6-12A1-4BFF-B817-02D48637289AQ30438814-C566AA99-B22B-41D2-A5D9-67BF5D9D5E99Q30439686-1E6CBAF4-AEB0-49DF-9EF0-ECC94886FC33Q30444285-69F9999D-2CAB-4F0C-B51E-82A4DAF95222Q30759253-D8CF9C05-31CF-4A00-9222-5C223B5245DBQ30868600-77F85036-1CA2-47BE-8A25-5292FF0B05A3Q31121927-67994C8A-E3AB-4929-9E0F-747BB24756D6Q31148183-155B5BA6-9BFD-400D-876C-A6F6AE4C37F9Q31153391-C4944AA6-8692-405E-991F-537AB7191D93Q31479337-21652EF8-9B57-4297-8EE0-0AE60B7C546BQ33230145-CAD70703-00E2-44F9-9ED6-F4484F2B0B14Q33233281-4366CD9D-52FF-4574-87AE-81FB5A1A08A4Q33241474-E87EB462-CFFD-495B-881D-6526496E23E8Q33436829-2EDE001E-E467-47D9-A952-229062EB82A7
P50
description
biochemicus
@nl
hulumtues
@sq
researcher
@en
ricercatore
@it
հետազոտող
@hy
name
Harald Mischak
@ast
Harald Mischak
@en
Harald Mischak
@es
Harald Mischak
@nl
Harald Mischak
@sl
type
label
Harald Mischak
@ast
Harald Mischak
@en
Harald Mischak
@es
Harald Mischak
@nl
Harald Mischak
@sl
prefLabel
Harald Mischak
@ast
Harald Mischak
@en
Harald Mischak
@es
Harald Mischak
@nl
Harald Mischak
@sl
P227
P244
P5361
P1153
7004897973
P19
P21
P214
5150686502812541725
P227
1156575222
P244
no2017123346
P31
P496
0000-0003-0323-0306
P5361
MischakHarald1961-
P569
1961-01-01T00:00:00Z
P735
P7859
lccn-no2017123346